Skip to main content
Erschienen in: Tumor Biology 12/2016

14.10.2016 | Original Article

Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells

verfasst von: Jin-Hua He, Bao-Xia Li, Ze-Ping Han, Mao-Xian Zou, Li Wang, Yu-Bing Lv, Jia-Bin Zhou, Ming-Rong Cao, Yu-Guang Li, Jing-zhi Zhang

Erschienen in: Tumor Biology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Rapidly accumulated evidence has shown that long non-coding RNA (lncRNAs) disregulation is involved in human tumorigenesis in many cancers, including prostate cancer (PCa). LncRNAs can regulate essential pathways that contribute to tumor initiation and progression with tissue specificity, which suggests that lncRNAs could be valuable biomarkers and therapeutic targets. Prostate cancer antigen 3 (PCA3), also known as differential display code 3 (DD3), is one such lncRNA that maps to chromosome 9q21–22. PCA3 expression is highly specific to PCa. In the present study, the level of PCA3 expression in prostate cancer cells was reduced by small interfering RNA (siRNA). Subsequently, the ability of LNCaP cell proliferation, invasion, and migration of PCa was compromised both in vivo and in vitro with the occurrence of cell autophagy. Recently, a novel regulatory mechanism has been proposed in which RNAs cross talk via competing with the shared microRNAs (miRNAs). In addition, lncRNAs can directly interact with RNA-binding proteins and then bind to the gene promoter region to further regulate gene expression. The proposed competitive endogenous RNAs mediate the bioavailability of miRNAs on their targets, thus imposing another level of post-transcriptional regulation. Here, we demonstrated that binding of Snail to the promoter region of PCA3 could activate the expression of PCA3. Down-regulation of PCA3 by silencing could increase the expression of the miRNA-1261, which then targeted at the PRKD3 gene (protein kinase D3) through competitive sponging. In summary, these results suggest that the transcription factor, Snail, activated the expression of lncRNA PCA3, which could inhibit the translation of PRKD3 protein via competitive miR-1261 sponging, and thus high expression of PRKD3 further promoted invasion and migration of prostate cancer.
Literatur
1.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA. 2013;63:11–30. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA. 2013;63:11–30.
2.
Zurück zum Zitat Roberts WB, Han M. Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer. Surgic Oncol. 2009;18:268–74.CrossRef Roberts WB, Han M. Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer. Surgic Oncol. 2009;18:268–74.CrossRef
3.
Zurück zum Zitat Han M, Partin AW, Pound CR, et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15 year Johns Hopkins experience. Urologic Clin North America. 2001;28:555–65.CrossRef Han M, Partin AW, Pound CR, et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15 year Johns Hopkins experience. Urologic Clin North America. 2001;28:555–65.CrossRef
5.
Zurück zum Zitat Chen G, Wang Z, Wang D, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–6.CrossRefPubMed Chen G, Wang Z, Wang D, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–6.CrossRefPubMed
6.
Zurück zum Zitat Geisler S, Coller JRNA. In unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013;14:699–712.CrossRefPubMedPubMedCentral Geisler S, Coller JRNA. In unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013;14:699–712.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ellis BC, Graham LD, Molloy PL. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta. 2014;1843:372–86.CrossRefPubMed Ellis BC, Graham LD, Molloy PL. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta. 2014;1843:372–86.CrossRefPubMed
8.
9.
Zurück zum Zitat Avgeris M, Stravodimos K, Fragoulis EG, et al. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. Brit J Cancer. 2013;108:2573–81.CrossRefPubMedPubMedCentral Avgeris M, Stravodimos K, Fragoulis EG, et al. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. Brit J Cancer. 2013;108:2573–81.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Juan L, Wang G, Radovich M, et al. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genet. 2013;6:S7. Juan L, Wang G, Radovich M, et al. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genet. 2013;6:S7.
12.
Zurück zum Zitat He JH, Zhang JZ, Han ZP, Wang L, Lv Y, Li YG. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res. 2014;33:72–7.CrossRefPubMedPubMedCentral He JH, Zhang JZ, Han ZP, Wang L, Lv Y, Li YG. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res. 2014;33:72–7.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ren S, Liu Y, Xu W, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190:2278–87.CrossRefPubMed Ren S, Liu Y, Xu W, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190:2278–87.CrossRefPubMed
14.
Zurück zum Zitat Popa I, Fradet Y, Beaudry G, et al. Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization. Modern Pathol. 2007;20:1121–7.CrossRef Popa I, Fradet Y, Beaudry G, et al. Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization. Modern Pathol. 2007;20:1121–7.CrossRef
15.
Zurück zum Zitat Bonfim-Silva R, Pimentel T, Valera ET, et al. Gene expression profile of long non-coding RNA EVF-2 in medulloblastoma cell lines and tissue samples. BMC Proc. 2013;7:61.CrossRef Bonfim-Silva R, Pimentel T, Valera ET, et al. Gene expression profile of long non-coding RNA EVF-2 in medulloblastoma cell lines and tissue samples. BMC Proc. 2013;7:61.CrossRef
16.
Zurück zum Zitat Wierzbicki AT. The role of long non-coding RNA in transcriptional gene silencing. Curr Opin Plant Biol. 2012;15:517–22.CrossRefPubMed Wierzbicki AT. The role of long non-coding RNA in transcriptional gene silencing. Curr Opin Plant Biol. 2012;15:517–22.CrossRefPubMed
17.
Zurück zum Zitat He JH, Li YM, Li YG, et al. hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide. Exp Ther Med. 2013;5:1315–21.PubMedPubMedCentral He JH, Li YM, Li YG, et al. hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide. Exp Ther Med. 2013;5:1315–21.PubMedPubMedCentral
18.
Zurück zum Zitat Zhang C, Fang X, Li W, et al. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells. Cancer Biocher Radiopharm. 2013;29:405–11. Zhang C, Fang X, Li W, et al. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells. Cancer Biocher Radiopharm. 2013;29:405–11.
19.
20.
Zurück zum Zitat Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–45.CrossRefPubMed Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–45.CrossRefPubMed
21.
Zurück zum Zitat Alali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013;8:e53823.CrossRef Alali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013;8:e53823.CrossRef
22.
Zurück zum Zitat Chen J, Deng F, Singh SV, et al. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res. 2008;58:3844–53.CrossRef Chen J, Deng F, Singh SV, et al. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res. 2008;58:3844–53.CrossRef
23.
Zurück zum Zitat Li JH, Liu S, Zhou H, LH Q, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7.CrossRefPubMed Li JH, Liu S, Zhou H, LH Q, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7.CrossRefPubMed
24.
Zurück zum Zitat Tao T, Li G, Dong Q, et al. Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-/PKM2 signaling pathway in prostate cancer cells. Tumour Biol. 2014;35:8543–50.CrossRefPubMed Tao T, Li G, Dong Q, et al. Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-/PKM2 signaling pathway in prostate cancer cells. Tumour Biol. 2014;35:8543–50.CrossRefPubMed
25.
Zurück zum Zitat Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–66.CrossRefPubMed Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–66.CrossRefPubMed
26.
Zurück zum Zitat Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013;8:e53823.CrossRefPubMedPubMedCentral Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013;8:e53823.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Schalken JA, Hessels D, Verhaegh G. New target S for therapy in prostate cancer: differential display code 3(DD3 PCA3), a highly prostate cancer-specific gene. Urology. 2003;62:34–43.CrossRefPubMed Schalken JA, Hessels D, Verhaegh G. New target S for therapy in prostate cancer: differential display code 3(DD3 PCA3), a highly prostate cancer-specific gene. Urology. 2003;62:34–43.CrossRefPubMed
28.
Zurück zum Zitat Gandini O, Luci L, Stigliano A, et al. Is DD3 a new prostate specific gene? Anticancer Res. 2003;23:305–8.PubMed Gandini O, Luci L, Stigliano A, et al. Is DD3 a new prostate specific gene? Anticancer Res. 2003;23:305–8.PubMed
29.
Zurück zum Zitat Jacques B, de Kok, Gerald W, et al. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695–8. Jacques B, de Kok, Gerald W, et al. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695–8.
30.
Zurück zum Zitat Hessels D, Klein Gunnewiek JM, Van Oort I, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8–16.CrossRefPubMed Hessels D, Klein Gunnewiek JM, Van Oort I, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8–16.CrossRefPubMed
31.
Zurück zum Zitat Tinz M, Marberger M, Horvath S, et al. DD3PCA3 RNA analysis in urine: a new perspective for detecting prostate cancer. Eur Urol. 2004;46:182–7.CrossRef Tinz M, Marberger M, Horvath S, et al. DD3PCA3 RNA analysis in urine: a new perspective for detecting prostate cancer. Eur Urol. 2004;46:182–7.CrossRef
32.
Zurück zum Zitat De Kok JB, Verhaegh JW, Roelofs RW, et al. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695–8.PubMed De Kok JB, Verhaegh JW, Roelofs RW, et al. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695–8.PubMed
33.
Zurück zum Zitat Javan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1051 men. J Urol. 2000;163:1144–9.CrossRef Javan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1051 men. J Urol. 2000;163:1144–9.CrossRef
34.
Zurück zum Zitat Verhaegh GW, van Bokhoven A, Smit F, et al. Isolation and characterization of the promoter of the human prostate cancer specific DD3 gene. J Biol Chem. 2000;275:37496–503.CrossRefPubMed Verhaegh GW, van Bokhoven A, Smit F, et al. Isolation and characterization of the promoter of the human prostate cancer specific DD3 gene. J Biol Chem. 2000;275:37496–503.CrossRefPubMed
35.
Zurück zum Zitat Cui Z, Ren S, Lu J, et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol. 2013;31:1117–23.CrossRefPubMed Cui Z, Ren S, Lu J, et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol. 2013;31:1117–23.CrossRefPubMed
36.
Zurück zum Zitat Ferreira LB, Palumbo A, de Mello KD, et al. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer. 2012;32:1–15. Ferreira LB, Palumbo A, de Mello KD, et al. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer. 2012;32:1–15.
37.
Zurück zum Zitat Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101–12.CrossRefPubMed Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101–12.CrossRefPubMed
38.
Zurück zum Zitat Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–69.CrossRefPubMedPubMedCentral Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–69.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014;114:1377–88.CrossRefPubMed Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014;114:1377–88.CrossRefPubMed
40.
Zurück zum Zitat Braconi C, Kogure T, Valeri N, et al. MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30:4750–6.CrossRefPubMedPubMedCentral Braconi C, Kogure T, Valeri N, et al. MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30:4750–6.CrossRefPubMedPubMedCentral
41.
43.
Zurück zum Zitat Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409–19.CrossRefPubMedPubMedCentral Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409–19.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Augoff K, McCue B, Plow EF, Sossey-Alaoui K. MiR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer. 2012;11:5–11.CrossRefPubMedPubMedCentral Augoff K, McCue B, Plow EF, Sossey-Alaoui K. MiR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer. 2012;11:5–11.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Feldstein O, Nizri T, Doniger T, Jacob J, Rechavi G, Ginsberg D. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage. Mol Cancer. 2013;12:131–5.CrossRefPubMedPubMedCentral Feldstein O, Nizri T, Doniger T, Jacob J, Rechavi G, Ginsberg D. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage. Mol Cancer. 2013;12:131–5.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Sun M, Liu XH, KH L, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4- IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014;5:e1298.CrossRefPubMedPubMedCentral Sun M, Liu XH, KH L, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4- IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014;5:e1298.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat He X, Tan X, Wang X, et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumor Biol. 2014;35:12181–8.CrossRef He X, Tan X, Wang X, et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumor Biol. 2014;35:12181–8.CrossRef
Metadaten
Titel
Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells
verfasst von
Jin-Hua He
Bao-Xia Li
Ze-Ping Han
Mao-Xian Zou
Li Wang
Yu-Bing Lv
Jia-Bin Zhou
Ming-Rong Cao
Yu-Guang Li
Jing-zhi Zhang
Publikationsdatum
14.10.2016
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 12/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5450-y

Weitere Artikel der Ausgabe 12/2016

Tumor Biology 12/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.